U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Medical Device | Nanotechnology
new antibody test only takes 10 minutes, no blood draw necessary
On Nov. 20, 2025, an interdisciplinary research team at the University of Pittsburgh has developed wearable biosensors that…
Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion total
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
Neurolgic Form of Equine Herpes Virus Confirmed Following Texas Event
On Nov. 19, 2025, the Texas Animal Health Commission (TAHC) received confirmation of equine herpes myeloencephalopathy (EHM), the…
Novartis announces plans to build flagship manufacturing hub in North Carolina
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
CSL injects $2.3b into US for valuable blood plasma
On Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
Arrowhead Pharma Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…
Type 1 diabetes cured in mice with gentle blood stem-cell and pancreatic islet transplant
On Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
Utah, South Carolina confirm more measles as CDC call suggests U.S. elimination status in jeopardy
On Nov. 18, 2025, state officials in Utah report 84 measles cases in the state in a weekly…
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
Biotechnology | Disease | FDA | Therapeutics
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
CRISPR breakthrough reverses chemotherapy resistance in lung cancer
On Nov. 17, 2025,In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have…
Agriculture | Artificial Intelligence | Biotechnology | Chemistry | Clinical Research | Diagnostics | Energy | Environmental | Infectious Disease | Marine Science | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Rare Disease | Therapeutics | Vaccine | Women's Health
NIH funding cuts have impacted more than 74,000 people enrolled in trials
On Nov. 17, 2025, a JAMA published study found that more than 74,000 people have had their lives…
First detection of H5N5 Avian influenza in a Human confirmed in Washington State resident
On Nov. 14, 2025, the Washington State Department of Health reported that a Grays Harbor resident who was…
Judge says he’ll approve opioid settlement with OxyContin maker Purdue and Sackler family
On Nov. 14, 2025, A federal bankruptcy court judge said he will approve OxyContin-maker Purdue Pharma’s latest deal…
Merck to Acquire Cidara Therapeutics for $9.2 Billion, Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
On Nov. 14, 2025, Merck and Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, announced that…
Ethiopia reports suspected viral haemorrhagic fever outbreak
On Nov. 13, 2025, the World Health Organization (WHO) reported that Health authorities in Ethiopia are carrying out…
New Jersey man’s death first one to be tied to tick-related meat allergy
On Nov. 13, 2025, a previously healthy New Jersey man has been identified by an allergist at the…
FDA Quietly Approves Denosumab Biosimilars, Issues Interchangeability for Others
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
Scientists unveil the world’s most comprehensive AI-powered tool for neuroscience: Brain Knowledge Platform
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…
Researchers pioneer greener way to extract rare earth elements
On Nov. 12, 2025, a team of University of California, Berkeley-led researchers reported in Nano Letters that they…
Biotechnology | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine | Women's Health
Stanford Medicine scientists tie lupus to a virus nearly all of us carry
On Nov. 12, 2025, Stanford Medicine scientists have found that the Epstein-Barr virus can convert B cells it’s…
RSV vaccine highly effective against hospital admission in older adults, study suggests
On Nov. 12, 2025, UK researchers reported a test-negative, case-control study across 14 hospitals in England finds that the…
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio for $4.9 billion
On Nov. 11, 2025, Pfizer and Metsera announced the companies have entered into a definitive agreement under which…
Animal testing to be phased out faster as UK unveils roadmap for alternative methods
On Nov. 11, 2025, the United Kingdom government announced that animal testing in science is set to be…
Artificial Intelligence | Biotechnology | Energy | Environmental | Forestry | Genomics | Infectious Disease | Nanotechnology | Neurology | Oncology | Pharmaceutical | Therapeutics | Vaccine
China’s new scientist visa is a ‘serious bid’ for the world’s top talent
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
Biotechnology | CDC | COVID-19 | Infectious Disease | Measles | Vaccine
Canada Loses Measles Elimination status after three decades
On Nov. 10, 2025, Canada has lost its measles elimination status after nearly three decades due to its…